Esperion Therapeutics, Inc. 4

No insider trades are reported; this filing only grants power of attorney for future ownership filings by John B. Harlow, Jr. at Esperion Therapeutics, Inc.

The provided document is not a Form 4 reporting an insider trade, but rather a limited power of attorney dated November 17, 2025, by which John B. Harlow, Jr. authorizes company officers (including Sheldon Koenig and Benjamin Looker) to sign and file SEC ownership forms (Forms 3, 4, 5 and Schedule 13D) on his behalf for Esperion Therapeutics, Inc. Because this instrument only delegates filing authority and does not disclose any actual acquisition, disposition, or award of securities, there are no insider transactions, prices, or changes in beneficial ownership to analyze from this filing alone.

Filing Facts

CIK

1434868

Ticker

ESPR

Form

4

Source Type

fda

Accession

0001628280-26-048003

Alert Tier

4